Reasoned opinion on the modification of the existing MRL(s) for bifenazate in citrus fruit, pome fruit, stone fruit, grapes, hops, strawberries, tomatoes, peppers, aubergines, melons and watermelons

摘要

In accordance with Article 6 of Regulation (EC) No 396/2005, The Netherlands received an application from Chemtura to modify the existing MRL(s) for the active substance bifenazate in citrus fruit, pome fruit, stone fruit, grapes, hops, strawberries, tomatoes, peppers, aubergines, melons and watermelons. In order to accommodate for the intended use of bifenazate, the evaluating Member State (EMS) proposed to raise the existing MRLs for all of the crops except for pepper where a lowering of the MRL was proposed, and for tomatoes and aubergines, where it was concluded that no modification of the MRL would be required. The EMS drafted an evaluation report according to Article 8 of Regulation (EC) No 396/2005, which was submitted to the European Commission and forwarded to EFSA on 6 January 2012. According to EFSA the data are sufficient to derive MRL proposals of 0.9 mg/kg for citrus fruit, 0.5 mg/kg for pome fruit, 0.5 mg/kg peachesectarines and plums, 0.7 mg/kg for grapes, 3 mg/kg for strawberries, 0.5 mg/kg for tomatoes and aubergines, 0.4 mg/kg for sweet pepper, 3 mg/kg for chilli pepper, 0.6 mg/kg for cucurbits with inedible peel and 20 mg/kg for hops. Adequate analytical enforcement methods are available to control the residues of bifenazate on the commodities under consideration at the validated LOQ of 0.01 mg/kg. Since for some of these crops higher MRLs were proposed in a previously issued reasoned opinion of EFSA, they need to be considered to avoid trade disruption. Based on the risk assessment results, EFSA concludes that the proposed use of bifenazate on citrus fruit, pome fruit, stone fruit, table‐ and wine grapes, strawberries, tomatoes, peppers, aubergines, melons, watermelons and hops will not result in a consumer exposure exceeding the toxicological reference value and therefore is unlikely to pose a consumer health risk.